DD

Dipjyoti Das

Active Director Director DIN 07642448
DIN 07642448 First appointment Nov 2016 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2016
Shareholding value •••• Premium profile

About Dipjyoti Das

Data last updated:

Dipjyoti Das is a Director at Xenichem Health Care Private Limited (since 2016). The company operates in Trading. Xenichem Health Care Private Limited reported revenue of ₹3.11 Cr (FY 2024).

DIN 07642448
Primary Designation Director
Industry Trading
First Appointment 08 Nov 2016
Oldest Company Age 10 yrs
Largest company Xenichem Health Care Private Limited · ₹3.11 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xenichem Health Care Private Limited U85320AS2016PTC017640
Director08 Nov 20162016₹3.11 Cr (FY 2024)Active

Board colleagues of Dipjyoti Das

Directorship timeline

Open interactive timeline →
Xenichem Health Care Private Limited
Premium access

Shareholding and investment profile for Dipjyoti Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dipjyoti Das

Dipjyoti Das currently holds 1 directorship: Xenichem Health Care Private Limited (Director, since 08 Nov 2016, revenue ₹3.11 Cr (FY 2024)).

Dipjyoti Das was first appointed on 08 Nov 2016 as Director at Xenichem Health Care Private Limited.

The current boards of Dipjyoti Das's companies include Biswajit Sarkar (Xenichem Health Care Private Limited), Raj Kumar Das (Xenichem Health Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available